Strahlentherapie des Endometriumkarzinoms im interdisziplinären Konzept

• Literatur

• 1 Sorbe B. Nordström B. Mäenpää J. et al. Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study. Int J Gynecol Cancer 2009; 19: 873-878
• 2 Ørtoft G. Dueholm M. Mathiesen O. et al. Preoperative staging of endometrial cancer using TVS, MRI, and hysteroscopy. Acta Obstet Gynecol Scand 2013; 92: 536-545
• 3 Nout RA. Smit VT. Putter H. et al. PORTEC Study Group, Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 2010; 375: 816-823
• 4 Nout RA. Putter H. Jürgenliemk-Schulz IM. et al. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol 2009; 27: 3547-3556
• 5 Kong A. Johnson N. Kitchener HC. et al. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis. J Natl Cancer Inst 2012; 104: 1625-1634
• 6 Creutzberg CL. van Putten WL. Wárlám-Rodenhuis CC. et al. Postoperative Radiation Therapy in Endometrial Carcinoma Trial, Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol 2004; 22: 1234-1241
• 7 Bosse T. Peters EE. Creutzberg CL. et al. Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer – A pooled analysis of PORTEC 1 and 2 trials. Eur J Cancer 2015; 51: 1742-1750
• 8 Osborn V. Schwartz D. Lee YC. et al. Patterns of care in IMRT usage in postoperative management of uterine cancer. Gynecol Oncol 2017; 144: 130-135
• 9 Maggi R. Lissoni A. Spina F. et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 2006; 95: 266-271
• 10 Randall ME. Filiaci VL. Muss H. et al. Gynecologic Oncology Group Study, Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 2006; 24: 36-44
• 11 Hogberg T. Signorelli M. de Oliveira CF. et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer – results from two randomised studies. Eur J Cancer 2010; 46: 2422-2431
• 12 van der Steen-Banasik E. Christiaens M. European Organisation for Research and Treatment of Cancer, Gynaecological Cancer Group (EORTC-GCG). et al. Systemic review: Radiation therapy alone in medical non-operable endometrial carcinoma. Eur J Cancer 2016; 65: 172-181
• 13 Denschlag D. Thiel FC. Ackermann S. et al. Sarcoma of the Uterus. Guideline of the DGGG (S2k-Level, AWMF Registry No. 015/074, August 2015). Geburtshilfe Frauenheilkd 2015; 75: 1028-1042
• 14 Reed NS. Mangioni C. Malmström H. et al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer 2008; 44: 808-818